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Abstract:  Plasticised poly(vinyl chloride)-based membranes containing the ionophores   
(α-, β- and γ-cyclodextrins (CD), dibenzo-18-crown-6 (DB18C6) and dibenzo-30-crown-10 
(DB30C10) were evaluated for their potentiometric response towards promethazine (PM) 
in a flow injection analysis (FIA) set-up. Good responses were obtained when   
β- and γ-CDs, and DB30C10 were used. The performance characteristics were further 
improved when tetrakis(4-chlorophenyl) borate (KTPB) was added to the membrane. The 
sensor based on β-CD, bis(2-ethylhexyl) adipate (BEHA) and KTPB exhibited the best 
performance among the eighteen sensor compositions that were tested. The response was 
linear from 1  10
−5 to 1  10
−2 M, slope was 61.3 mV decade
−1, the pH independent 
region ranged from 4.5 to 7.0, a limit of detection of 5.3  10
−6 M was possible and a 
lifetime of more than a month was observed when used in the FIA system. Other 
plasticisers such as dioctyl phenylphosphonate and tributyl phosphate do not show 
significant improvements in the quality of the sensors. The promising sensors were further 
OPEN ACCESSSensors 2011, 11                                       
 
 
1029
tested for the effects of foreign ions (Li
+, Na
+, K
+, Mg
2+, Ca
2+, Co
2+, Cu
2+, Cr
3+, Fe
3+, 
glucose, fructose). FIA conditions (e.g., effects of flow rate, injection volume, pH of the 
carrier stream) were also studied when the best sensor was used (based on β-CD). The 
sensor was applied to the determination of PM in four pharmaceutical preparations and 
human urine that were spiked with different levels of PM. Good agreement between the 
sensor and the manufacturer’s claimed values (for pharmaceutical preparations) was 
obtained, while mean recoveries of 98.6% were obtained for spiked urine samples. The 
molecular recognition features of the sensors as revealed by molecular modelling were 
rationalised by the nature of the interactions and complexation energies between the host 
and guest molecules. 
Keywords: flow injection analysis; ionophore; potentiometric sensor; promethazine 
 
1. Introduction  
Promethazine hydrochloride (PM) [(RS)-N,N-dimethyl-1-(10H-phenothiazine-10-yl)propan-2-amine 
hydrochloride] is a phenothiazine derivative (Figure 1). It is a first generation H1 receptor antagonist, 
antihistamine and antiemetic medication and can also have strong sedative effects [1-3]. The function 
of PM is to block histamine H1 receptors without blocking the secretion of histamine. 
Figure 1. Structure of promethazine. 
 
Several methods including high-performance liquid chromatography (HPLC) [1-4] capillary 
electrophoresis [5,6] spectrophotometry [7] chemiluminescence [8] and voltammetry [9] have been 
used for the determination of PM. Recently, the flow injection analysis (FIA) technique combined with 
different detection systems such as spectrophotometry [10,11] fluorimetry [12] and potentiometry [13] 
have been used for the assay of PM in pharmaceutical formulations. However, most of these methods 
are complicated, time consuming and also require expensive instrumentation. The spectrophotometric 
methods in particular suffer from interference problems if no effective pretreatment is in place. The 
oxidised form of PM is unstable which requires a rapid and fully automated reagent handling   
technique [10-12]. Thus, there is a need for simpler, low-cost, sensitive and rapid alternative methods 
for the determination of PM in real samples. 
Recent developments, especially in the late 1990s, have clearly shown the great promise of the 
potentiometric sensor (PS) for use with real samples. The dramatic lowering of detection limits   Sensors 2011, 11                                       
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to 10
−8–10
−11 M, polyion sensing [14,15] sensors for neutral analytes, etc. are som e of  these exciting 
developments. PS’ have found diverse applications including environmental [16] and drug analysis [17]. 
Several reports on the development and application of PM sensors for the determination of PM in 
pharmaceutical preparations [18-20] can be found in the literature. These are all based on   
ion-pairing agents that are plagued by limited selectivity, thus their applications are restricted to 
samples with simple matrices such as pharmaceutical preparations. For PM sensors to be applicable in 
more challenging matrices (e.g., real body fluids), a more selective molecular recognition component 
is clearly required. To this end interesting PS’, capitalising on the selective host-guest inclusion 
complexes using ionophores such as calixarenes [21], crown ethers and cyclodextrins (CDs) [22-25] 
for the sensing of drugs have been reported.  
This study aims in developing a simple, rapid and selective PM sensor that can be used for the 
determination of PM in real samples. The strategy was to explore the PM sensing capabilities of 
ionophores such as CDs (α-, β- and γ-CD) and crown ethers (DB18C6 and DB30C10), and exploiting 
the best system as a flow-through detector in a FIA set-up. Molecular modelling was also used to 
investigate the nature of the host-guest interaction(s). 
2. Materials and Methods 
2.1. Reagents and Chemicals 
All chemicals were of analytical grade and used as received. High-molecular-weight   
poly(vinyl chloride) (PVC), potassium tetrakis(4-chlorophenyl)-borate (KTPB), dibenzo-18-crown-6 
(DB18C6), and tetrahydrofuran (THF) were obtained from Fluka AG (Switzerland). PM hydrochloride, 
dioctylphenylphosphonate (DOPP), bis(2-ethylhexyl) adipate (BEHA), dibenzo-30-crown-10 
(DB30C10), α-, β-, γ-CD and tri-n-butyl phosphate (TBP) were purchased from Sigma-Aldrich (USA). 
PM syrups and tablets were purchased from local pharmacies. Doubly deionised water was used to 
prepare all solutions. A stock solution of 0.1 M PM was prepared by dissolving an appropriate amount 
of PM in 50 mL water. Standard solutions (1 × 10
−2 to 1 × 10
−6 M) PM were prepared fresh by diluting 
the appropriate amount of PM in water. Each stock solution was protected from light by wrapping the 
flasks with aluminium foil and stored in a refrigerator when not in use. Stock solutions (0.1 M) of 
various salts and sugars were also prepared. Other solutions were prepared by the subsequent dilutions 
of the stock solutions. 
2.2. Apparatus 
The FIA system (Figure 2) consisted of a multi-channel peristaltic pump (Gilson Miniplus 3) and an 
injection valve (Rheodyne Type 500 Teflon rotary selection valve), with an exchangeable sample loop. 
The rest of the FIA tubings were of 0.80 mm i.d. A sampling volume of 150 μL and carrier flow rate  
of 2.83 mL min
−1 were used throughout. The flow-through cell was of wall-jet design with a built-in 
Ag/AgCl reference electrode (Model FIP-3, Chemflow Devices, Australia) [26]. The sample was 
injected into a carrier stream of acetate buffer (0.1 M, pH 6.0). Potassium chloride (0.1 M) was used as 
reference solution. Potentiometric measurements were performed at 25 ± 2 °C using an Orion   Sensors 2011, 11                                       
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model 701A digital ionanalyser that was connected to the flow cell. A glass electrode, connected to an 
Orion expandable ionanalyser (model EA 940) was used to measure the pH of aqueous solutions. 
Figure 2. Schematic diagram of the FIA manifold. 
 
2.3. Preparation of the Promethazine Sensor 
Potentiometric PM selective sensors was prepared by dissolving PVC (176.0 mg), plasticising 
solvent (356.4 mg), ionophore (11.0 mg) and KTPB where appropriate (6.6 mg) in THF (5 mL). Four 
drops of the mixture were deposited on the electrode body [26] and the system was allowed to 
evaporate for 3 h. The membrane was then conditioned in 1 × 10
−2 M PM for 1 h prior to use. PM 
standard solutions covering the range 1×10
−6 to 1×10
−1 M was injected into the FIA unit. Each solution 
was measured in triplicate. The average potentials at maximum heights were plotted against log [PM]. 
2.4. Selectivity  
Selectivity coefficients,
pot
B A, K , of the fabricated sensors towards several cations and sugars were 
measured using the separate solution method [27] and the following equation was applied: 
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where EA and EB are the potential readings of PM and interferring ions, respectively; aA is the activity 
or concentration of PM. ZA and ZB are the charge of PM and interferring ions, respectively and S is the 
slope of the calibration graph. 
2.5. Determination of PM in Pharmaceutical Preparations and Human Urine 
The United States Pharmacopoeia method [28] was used for the determination of PM in certain 
samples as comparison to the proposed method. 
2.5.1. Tablets 
A homogenised powder was prepared from ten accurately weighed tablets. An appropriate amount 
of this powder was dissolved in water in a 50 mL Erlenmeyer flask. The dissolution of the drug was Sensors 2011, 11                                       
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assisted by means of a magnetic stirrer and by an ultrasonic bath. The mixture was then filtered and 
made up to the mark with water in a 100 mL volumetric flask.  
2.5.2. Syrup 
An appropriate amount of syrup containing 1 and 3 mg mL
−1 of PM (as claimed by the 
manufacturers) was diluted with doubly deionised water in a 50 mL Erlenmeyer flask. 
2.5.3. Human Urine 
Appropriate volumes of standard PM solution were spiked into 10 mL Erlenmeyer flasks, and was 
topped-up to the mark with urine of healthy student volunteers. 
2.6. Computational Methods 
The starting geometries of PM and the host structures (-CD, -CD, -CD, DB18C6 and DB30C10) 
were built based on the structures that were generated from the crystallographic parameters provided 
by the Cambridge Structural Database (CSD) [29-33] and were separately optimised using the semi 
empirical method, PM3 using Gaussian03 software package [34]. The starting geometries of the 
inclusion complexes were constructed using HyperChem (Version 7.0, Hypercube, Gainesville, FL, 
USA). The previously optimised structures of PM and host molecules were allowed to approach each 
other along the symmetric axis (the X-axis) passing through the center of the host cavity. For example, 
in the case of -CD, the coordinate system used to define the process of complexation was based on 
constructing the CD with the seven identical glucose units positioned symmetrically around the Z-axis, 
such that all the glycosidic oxygens are in the XY plane and their center was defined as the center of 
the coordination system [35]. The PM molecule was docked into the cavity of the CD with the central 
nitrogen atom connecting the two benzene rings that coincides with the Z-axis. Docking was initially 
done to maximise the electrostatic and hydrophobic interactions between the host and the guest 
molecules. Multiple starting points were generated by moving the guest molecules along the – and + 
Z-axis from 10 to −10 Å, at 1 Å intervals, and by rotating the guest molecules from 0°–360° at 45° 
intervals. Three different inclusion orientations, i.e., the nitrogen from the alkyl group of the PM 
vertically, facing up and down horizontally into the cavity of the host, were considered for each case 
(Figure 3).  
The inclusion interactions were simulated in vacuum and the presence of water molecules were 
ignored to save computational time especially for large molecules. The complexation energy, Ecomp, 
was calculated for the minimum energy structures by the following equation: 
Ecomp = Ecomp − EG − EH                  (2) 
where Ecomp, EG, and EH represent the total energy of the host-guest complex, the free guest molecule 
and the free host molecule, respectively. The magnitude of the energy change is an indication of the 
driving force towards complexation. The more negative the complexation energy change, the more 
thermodynamically favourable is the inclusion complex.  Sensors 2011, 11                                       
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Figure 3. The three different orientations considered for the insertion of promethazine into 
the cavity of the host molecules with the N atom from the alkyl group of promethazine 
moving in (a) vertically, (b) facing up, and (c) down horizontally. 
 
3. Results and Discussion  
The response of ionophore-based PS is very much governed by the molecular recognition ability 
between the analyte (guest) and the host molecule. The interactions between the guests and CDs are 
mainly facilitated by the hydrophobic interactions of the hydrophobic benzene ring of the guest which is 
presumably included in the hydrophobic cavity of the CD receptor [36] The formation of inclusion 
complexes of crown ethers with not only metal ions, but also organic molecules such as amines is also 
well-known. CDs are cyclic oligosaccharides that consist of D-glucopyranose residues linked to one 
another with α-1,4-glycosidic bonds. The most frequently used CDs are those containing six, seven and 
eight  α-D-glucose units (commonly referred to as α-,  β- and γ-CDs, respectively) with truncated 
cylindrical molecular shapes providing a hydrophobic cavity [37]. An important property of CDs is their 
ability to form inclusion complexes with a large number of organic and inorganic compounds―a 
property that has been exploited in pharmaceutical formulations of certain drugs [36]. Their unique 
ability to recognise different forms of enantiomers readily lend themselves in the separation of chiral 
molecules (e.g., in CE) and in chiral drug sensing [23,36]. 
The mechanism of the membrane response of the solid-state sensor is believed to be as proposed by 
Bakker and Pretsch [38]. Promethazine cation is transported through the sensing membrane and then  
to the redox-active monolayer that produces electrons which are measured by the metal   
platinum electrode. 
3.1. Effect of Membrane Composition 
Initially, the effect of the type of ionophore on the sensor performance was investigated using 
BEHA as plasticiser. Membranes using α-CD and DB18C6 (sensors 2 and 5, Table 1) resulted in  
non-functional sensors.  
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Table 1. Effect of membrane composition on the characteristics of promethazine sensors. 
Sensor 
No. 
Plasticiser, %  Ionophore  Additive 
Slope (mV 
decade
−1) 
Correlation 
coefficient 
Linear 
range (M) 
LOD 
(M) 
1  BEHA (65.8)  -  KTPB   48.6  0.9950  5 × 10
−5–1 × 10
−2  5 × 10
−5 
2 BEHA  (66.0) α-CD   -  1.12  -  -  - 
3 BEHA  (66.0) β-CD   -  50.9  0.9938  1 × 10
−4–1 × 10
−2  9 × 10
−5 
4 BEHA  (66.0) γ-CD   -  52.1  0.9972  1 × 10
−4–1 × 10
−2  7 × 10
−5 
5  BEHA (66.0)  DB18C6   -  Unstable  -  -  - 
6  BEHA (66.0)  DB30C10   -  49.1  0.9991  1 × 10
−4–1 × 10
−2  8 × 10
−5 
7 BEHA  (68.0)  -  -  Unstable  -  -  - 
8 DOPP  (68.0)  -  -  Unstable  -  -  - 
9 TBP  (68.0)  -  - Unstable  -  -  - 
10 BEHA  (64.8) β-CD   KTPB   61.3  0.9996  1 × 10
−5–1 × 10
−2  5 × 10
−6 
11 BEHA  (64.8)  γ-CD   KTPB   55.2  0.9976  1 × 10
−5–1 × 10
−2  9 × 10
−6 
12  BEHA (64.8)  DB30C10   KTPB   55.8  0.9988  1 × 10
−5–1 × 10
−2  1 × 10
−5 
13 DOPP  (64.8) β-CD   KTPB   57.8  0.9973  1 × 10
−5–1 × 10
−2  9 × 10
−6 
14 DOPP  (64.8) γ-CD   KTPB   51.1  0.9942  1 × 10
−5–1 × 10
−2  9 × 10
−6 
15  DOPP (64.8)  DB30C10   KTPB   47.0  0.9989  5 × 10
−5–1 × 10
−2  5 × 10
−5 
16 TBP  (64.8) β-CD   KTPB   52.1  0.9990  1 × 10
−4–1 × 10
−2  5 × 10
−5 
17 TBP  (64.8) γ-CD   KTPB   49.5  0.9947  1 × 10
−4–1 × 10
−2  5 × 10
−5 
18  TBP (64.8)  DB30C10   KTPB   40.2  0.9946  1 × 10
−4–1 × 10
−2  7 × 10
−5 
The cavities of these hosts are probably too small [α-CD (174 Å)] [35] to accommodate the guest 
molecule. When hosts with larger cavity sizes ([β-CD (262 Å), γ-CD (427 Å) and DB30C10] were 
used, promising PM sensors were obtained. The characteristics of these sensors were further improved 
by adding KTPB as membrane additive (sensors 10–12), and near Nernstian responses were obtained. 
Several different membrane compositions that contained 1.0, 1.2, 1.6, and 2.0% of KTPB were also 
investigated. The best composition of KTPB, resulting in better slope, correlation coefficient and wide 
concentration range was 1.2%, therefore this amount of KTPB was used in all membranes. The 
beneficial effects of adding additives such as KTPB have been noted for reducing the membrane 
resistance and suppressing the permeation of counter anions in aqueous phase into the membrane 
phase [25,39]. On the contrary, sensors without the additive (sensors 3, 4 and 6) exhibited shorter 
linear range and produced sub-Nernstian slopes. It has been reported that in the absence of an 
additional lipophilic anion exchanger, poor performance may be caused by possible trace anionic 
impurities within the PVC used [39]. Non-functional sensors were obtained with membranes that only 
contained plasticisers (sensors 7–9). The observed effects of the membrane compositions on the sensor 
response are clear indicators that inclusion complexes were formed between the larger cavity hosts and 
the PM guest molecule. 
3.2. Optimisation of FIA Parameters 
3.2.1. Effect of Carrier Stream pH and Concentration 
This was studied by changing the carrier stream pH from 1.0 to 8.0 and measuring the peak heights 
of injected standard solution of PM. The peak height increases steadily over pH 1.0 to 4.5 but remains Sensors 2011, 11                                       
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constant from pH 4.5 to 7.0, and decreases abruptly from pH 7.0 onwards (Figure 4). At pH values 
below 4.5 the interference of hydronium ion is expected, while at pH above 7.0, reduction in signal is 
most probably attributed to the formation of the free PM base [18]. The effect of acetate buffer 
concentration (0.1 to 0.5 M) was also investigated. It was found that there was no significant 
differences in the peak heights over this concentration range. Thus, a carrier stream of 0.1 M acetate 
buffer (pH 6.0) was used for the rest of the studies. 
Figure 4. pH profile of sensor no. 10. Carrier stream, 0.1 M acetate buffer; injection   
loop, 150 μL; flow rate; 3.25 mL min
−1. 
 
3.2.2. Effect of Sample Volume 
The effect of injected sample volume (50 to 400 μL) was studied by injecting 1 × 10
−3 M PM into 
the FIA unit. Peak heights were found to increase with increasing injected volume but a 150 μL sample 
loop was used as it provided a good compromise between sensitivity and speed of analysis.  
3.2.3. Effect of Flow Rate 
1 × 10
−3 M PM was injected under different flow rates (0.74 to 4.55 mL min
−1) using a carrier 
stream of 0.1 M acetate buffer (pH 6.0) and 150 μL injection loop. It was found that, as the flow rate 
increased, the peaks became higher and narrower until a flow rate of 2.83 mL min
−1 was reached. This 
flow rate was used throughout this work, as higher flow rates resulted in the consumption of higher 
amounts of solvents and chemicals. 
 
3.3. Lifetime  
The lifetime of the sensors were studied by continuously pumping for 300 min and repeatedly 
injecting 1 × 10
−3 M PM at 30 minute intervals (Figure 5). No noticeable reduction in peak heights 
over this period was observed for sensor 10. In contrast, sensors that were plasticised with DOPP and 
TBP (sensors 13 and 16, respectively) experienced a marked reduction in peak height after 60 minutes 
of continuous use. Indeed, it was found that sensor 10 remained operational over one month of   
daily use.  
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Figure 5. Lifetime studies of promethazine sensors based on β-CD with different 
plasticizer (sensors 10, 13 and 16). Peak heights from the injection of promethazine 
standards at regular interval were noted when continuously pumped with carrier stream. 
 
3.4. Selectivity  
Selectivity is an important characteristic of a sensor that delineates the extent to which the device 
may be used in the estimation of an analyte ion in the presence of other ions and extent of utility of the 
sensor in real sample measurements. The selectivity coefficient ( ) of the sensor was determined 
using the separate solution method [27] at a fixed concentration of 1 × 10
−3 M for both drug and 
interfering ions. Table 2 shows that there are no significant interferences from the cations, 
trifluoperazine and the sugars tested. Insignificant interferences from the alkali and alkaline earth 
metal ions suggest the good prospect of the sensor to be used in biological fluids. The overall 
selectivity of sensor 10 is better than that of sensors that are based on γ-CD or DB30C10   
(sensors 11 and 12). 
Table 2. Selectivity coefficients of promethazine sensors towards cations, trifluoperazine and sugars. 
Foreign ion 
log  
Sensor 10  Sensor 11  Sensor 12 
Li
+  –3.87 –3.66 –3.89 
Na
+  –4.06 –3.77 –2.42 
K
+  –3.58 –2.93 –2.06 
Mg
2+  –4.42 –3.71 –3.08 
Ca
2+  –3.83 –4.25 –3.28 
Co
2+  –4.77 –3.33 –2.95 
Cu
2+  –4.29 –4.12 –3.81 
Cr
3+  –4.64 –5.11 –4.86 
Fe
3+  –5.35 –4.98 –5.02 
Glucose  –4.61 –4.20 –3.64 
Fructose  –5.01 –4.63 –4.12 
Trifluoperazine  –2.85 –3.04 –2.20 
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Under the optimum conditions, response time of not more than 5 s was obtained for an injected 
sample, translating into a sample throughput of about 96 samples h
−1 .The FIA system was 
characterised by a dispersion coefficient of 1.9, which was calculated using the equation:  
D = ho/h                    (3) 
where ho and h is the peak height for undispersed and dispersed sample, respectively. The limited 
dispersion obtained indicate the limited mixing of analyte and solutions in the flow system, ensuring a 
sensitive detector output. 
 
3.5. Analysis of Real Samples  
 
3.5.1. Determination of PM in Pharmaceutical Formulations 
 
The analytical usefullness of the sensor was tested by determining the concentration of PM in 
solutions of syrups and tablets. Good agreement of results from the manufacturer’s claimed values, the 
reference USP and from the proposed FIA sensor was obtained for all the samples tested (Table 3). 
 
Table 3. FIA determination of promethazine in syrups, tablets and spiked urine samples 
using sensor no.10. 
Type of Sample 
Taken/M 
FIA Method  USP Method 
(Manufacturer)  % Rec.  % RSD
d  % Rec.  % RSD
d 
Promethazine /syrup
a  1 × 10
−3  104 2.3  102.9  0.82 
(DHA, Singapore)  1 × 10
−4  102 0.92  99  1.13 
Phenergan/oral solution
a  5 × 10
−4  100 0.13  99.2  0.54 
(Sanofi-Winthrop Industrie, France)  5 × 10
−5  99.2 0.51  98.4  0.7 
Upha Promethazine/syrup
b  1 × 10
−4  107 0.84  103.6  0.65 
(CCM Pharmaceutical, Malaysia)  5 × 10
−5  101 1.9  99.0  0.85 
Upha Promethazine/tablets
c  5 × 10
−3  101 0.77  98.0  0.6 
(CCM Pharmaceutical, Malaysia)  1 × 10
−4  99.4 0.53  98.4  0.48 
Urine 1  1 × 10
−3  99 1.04  -  - 
Urine 2  1 × 10
−4  97.5 1.49 -  - 
Urine 3  1 × 10
−5  99.2 1.37 -  - 
a.  PM 5 mg/5 mL. 
b.  PM 15 mg/5 mL. 
c.  PM 25 mg/tablet. 
d.  Average of six determinations. 
RSD, relative standard deviation 
Rec., Recovery 
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3.5.2. Determination of PM in Spiked Human Urine 
 
The capability of the sensor was further tested for the determination of PM in undiluted human 
urine that had been spiked with three levels of PM. Results obtained are listed in Table 3. The good 
recoveries demonstrate the applicability of the sensor for routine analysis without prior   
sample pretreatment. 
 
3.6. Molecular Modelling 
 
To further understand how molecular recognition takes place at the atomic level, molecular 
modelling techniques were used to complement the experimental studies. The complexation energies 
(Ecomp) of the PM inclusion complexes are listed in Table 4. The optimised geometries for the lowest 
energy conformation for the inclusion complexes of PM with CDs and dibenzo-crown ethers are 
shown in Figure 6, respectively. In general, the inclusion complexes of CDs with PM have larger 
binding energies when compared to their dibenzocrown ethers counterpart. The overall lowest binding 
energies with the different hosts decrease in the order of: -CD > -CD > -CD > DB30C10 > DB18C6. 
 
Table 4. Molecular modelling results of interaction energies (Ecomp in kcal mol
−1) of the 
optimal configurations of (1:1) promethazine/CDs and promethazine/dibenzocrown ether 
inclusion complexes. 
Host Ecomp (kcal mol
−1) 
-CD –17.134 
-CD –20.384 
-CD –21.378 
DB18C6 81.467 
DB30C10 –16.826 
 
The dominant driving force for the complexation is evidently H-bondings interaction. Close 
observation on the structure of the inclusion complexes shows that -CD complexes have more   
H-bonding interactions compared to the -CD complexes. Various authors have also reported that 
intermolecular hydrogen bondings between the host-guest interactions resulting from the fitting of 
small molecules into the CD cavities play an important role in the binding energies of a number of CD 
inclusion complexes [40,41].
 An almost complete inclusion of the guest molecule was observed for the 
promethazine/-CD complex (Figure 6(c)). Meanwhile, for the promethazine/-CD complex, only the 
N-alkyl group is included leaving the aromatic rings protrude outside the cavity (Figure 6(b)). 
However, for the -CD the N-alkyl group barely touches the upper rim of the -CD (Figure 6(a)). 
Consistently, no H-bondings were observed for -CD and that of the crown ether complexes. The high 
and positive complexation energy displayed by promethazine/DB18C6 complex (Table 4), shows that 
inclusion complex between the two molecules are highly unfavourable from the theoretical point of 
view, consistent with the experimental observations. 
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Figure 6. The energy minimised structures obtained from PM3 calculations for the side 
and top view of (a) promethazine/α-CD, (b) promethazine/β-CD, (c) promethazine/γ-CD, 
(d) promethazine/DB18C6, and (e) promethazine/DB30C10 complexes. 
 
4. Conclusions  
Good quality PM potentiometric sensors were realised using some relatively large cavity size 
ionophores such as β-CD, γ-CD and DB30C10. The sensor based on β-CD, plasticised with BEHA and 
containing KTPB additive offers the best overall sensor characteristics, especially in terms of 
selectivity. The integration of the sensor to a FIA system resulted in a selective device that enables the 
rapid determination (sample throughput, 96 samples h
−1) of PM in pharmaceutical preparations and 
human urine. The proposed FIA system is superior to the other analytical techniques based on   
HPLC [3,4] as it is not only rapid but uses very simple, and cheap instrumentation. Other advantageous 
features of potentiometric-type sensors such as the ability to function even in turbid and coloured 
environments have been well-noted. Although the molecular modelling work that was carried out was 
somewhat simplistic in the sense that interactions from the plasticiser was excluded, nevertheless they 
provide valuable insights into the nature of interactions between the hosts and guest molecules. 
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